Patent details

Basic Information

Publication number:

EP3662912

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP192075869

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMPROVED DOSAGES OF ETEPLIRSEN FOR TREATING DUCHENNE MUSCULAR DYSTROPHY

French Title of Invention:

DOSAGES D'ETEPLIRSEN AMÉLIORÉS POUR LE TRAITEMENT DE LA DYSTROPHIE MUSCULAIRE DE DUCHENNE

German Title of Invention:

VERBESSERTE ETEPLIRSEN DOSIERUNGEN ZUR BEHANDLUNG VON DUCHENNE MUSKELDYSTROPHIE

SPC Number:

Dates

Filing date:

14/03/2014

Grant date:

03/12/2025

EP Publication Date:

10/06/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/12/2025

EP B1 Publication Date:

03/12/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

14/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/11/2025

 

 

Name:

Sarepta Therapeutics, Inc.

Address:

215 First Street, Cambridge, MA 02142, United States (US)

Inventor

Name:

KAYE, Edward M.

Address:

United States (US)

Priority

Priority Number:

201361793463 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/7125; A61P 21/00; A61P 1/00; A61P 21/02;

Publication

European Patent Bulletin

Issue number:

202549

Publication date:

03/12/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/03/2026

Annual Fee Number:

13

Annual Fee Amount:

180 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages